4.8 Article

Conduction Cooling and Plasmonic Heating Dramatically Increase Droplet Vitrification Volumes for Cell Cryopreservation

Journal

ADVANCED SCIENCE
Volume 8, Issue 11, Pages -

Publisher

WILEY
DOI: 10.1002/advs.202004605

Keywords

cell therapy; conduction cooling; cryopreservation; droplet vitrification; plasmonic laser heating

Funding

  1. NIH SBIR Phase I [1R41OD024430-01]
  2. NIH SBIR Phase II [9R44MH122118-02]
  3. University of Minnesota
  4. National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [DP2EB020537]

Ask authors/readers for more resources

A novel approach has been developed to achieve high viability in microliter-size droplets using gold nanorods and plasmonic laser heating. This new method demonstrates significantly improved cooling and warming rates compared to traditional convective heat transfer methods.
Droplet vitrification has emerged as a promising ice-free cryopreservation approach to provide a supply chain for off-the-shelf cell products in cell therapy and regenerative medicine applications. Translation of this approach requires the use of low concentration (i.e., low toxicity) permeable cryoprotectant agents (CPA) and high post cryopreservation viability (>90%), thereby demanding fast cooling and warming rates. Unfortunately, with traditional approaches using convective heat transfer, the droplet volumes that can be successfully vitrified and rewarmed are impractically small (i.e., 180 picoliter) for m permeable CPA. Herein, a novel approach to achieve 90-95% viability in micro-liter size droplets with 2 m permeable CPA, is presented. Droplets with plasmonic gold nanorods (GNRs) are printed onto a cryogenic copper substrate for improved cooling rates via conduction, while plasmonic laser heating yields >400-fold improvement in warming rates over traditional convective approach. High viability cryopreservation is then demonstrated in a model cell line (human dermal fibroblasts) and an important regenerative medicine cell line (human umbilical cord blood stem cells). This approach opens a new paradigm for cryopreservation and rewarming of dramatically larger volume droplets at lower CPA concentration for cell therapy and other regenerative medicine applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available